Invention Grant
- Patent Title: Complement component C5 antibodies
-
Application No.: US15943192Application Date: 2018-04-02
-
Publication No.: US10752678B2Publication Date: 2020-08-25
- Inventor: Peter C. Baciu , Yanbin Liang , Jason Guu , Matthew Bernett , Umesh Muchhal , John Desjarlais
- Applicant: Allergan, Inc. , Xencor, Inc.
- Applicant Address: US CA Irvine US CA Monrovia
- Assignee: ALLERGAN, INC.,XENCOR, INC.
- Current Assignee: ALLERGAN, INC.,XENCOR, INC.
- Current Assignee Address: US CA Irvine US CA Monrovia
- Agency: Morgan, Lewis & Bockius LLP
- Agent Nathan S. Smith; Christopher J. Betti
- Main IPC: C07K16/18
- IPC: C07K16/18 ; A61K39/395 ; A61K39/00
Abstract:
The present disclosure relates to antibodies and polynucleotides encoding the same, that may be used to prevent, control, or reduce the activity of the complement pathway. In addition, the disclosure is directed to compositions and methods for diagnosing and treating diseases mediated by or involving complement C5. Specifically, the disclosure is related to C5 antibodies.
Public/Granted literature
- US20180222969A1 COMPLEMENT COMPONENT C5 ANTIBODIES Public/Granted day:2018-08-09
Information query
